This Week’s Dose: Speaker Pelosi’s announcement of an impeachment inquiry dominated the news this week, but what does that mean for health care policy?

M+ Check-Up: July 26, 2019

This Week’s Dose: The Senate Finance Committee finally released its drug pricing package and moved quickly to a markup. The bill passed out of committee, but work will continue before the ful...

This Week’s Dose: The Energy and Commerce Committee held a marathon mark-up of 25 bills, including 10 health care related bills. The No Surprises Act received an amendment that adds arbitrati...

The last week before recess is shaping up to be a busy one. All Eyes on the Administration. The Administration is expected to release a transparency executive order as early as today. This executive order is rumored to direct ag...

Where do we stand with only three weeks until the July 4^th break? The Focus is Back on Surprise Billing. Surprise billing will not be going away any time soon. In fact, with the Congressional Budget O...

This Week’s Dose: Another busy week for prescription drug pricing. Two more hearings took place on the subject, and a handful of bills passed out of the House. Now we watch the Senate to see ...

This Week’s Dose: Lots of activity surrounding single-payer this week with a hearing, the introduction of two Medicare expansion bills and a report from the Congressional Budget Office (CBO)....

They’re back… Congress is back from recess and now heads into a four week work stretch. The next four weeks will be important to watch for progress on legislation. A numbe...

This Week’s Dose: When Congress is away, the agencies will play. The Administration made some major announcements and dropped several new important rules this week, giving stakeholders plenty...

This Week’s Diagnosis: Government reopens…for at least three weeks. Congress is full steam ahead, kicking off the 116^th with health care hearings on drug pricing and pre-existing...